Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Intensivmedizin + Notfallmedizin : Organ Der Deutschen Und Der Osterreichischen Gesellschaft Fur Internistische Intensivmedizin, Der Sektion Neurologie Der DGIM Und Der Sektion Intensivmedizin Im Berufsverband Deutscher Internisten E.V|April 15, 2020
[Continuous fecal drainage systems in intensive care medicine]O Rothaug, A Kaltwasser, R Dubb, et al.European Journal of Biochemistry|July 1, 1997
Mode of primary binding to target membranes and pore formation induced by Vibrio cholerae cytolysin (hemolysin)A Zitzer, M Palmer, U Weller, et al.World Journal of Urology|December 6, 2018
Surgical treatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approachSebastian Nestler, T Bach, T Herrmann, et al.Animal : an International Journal of Animal Bioscience|August 10, 2017
Invited review: A position on the Global Livestock Environmental Assessment Model (GLEAM)M J MacLeod, T Vellinga, C Opio, et al.Aktuelle Urologie|November 18, 2015
[Partial Nephrectomy in cT1 Renal Tumours: Conventional Laparoscopic Partial Nephrectomy Compared with LESS Partial Nephrectomy in SITUS Technique]M Wolters, L Wohlatz, T Neumann, et al.Journal of Applied Microbiology|August 20, 2005
Detection of Mycobacterium avium subspecies paratuberculosis in Swiss dairy cattle by real-time PCR and culture: a comparison of the two assaysK Bögli-Stuber, C Kohler, G Seitert, et al.Hemasphere|November 15, 2019
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease CloneJonas S Jutzi, Maria Kleppe, Jennifer Dias, et al.Leukemia|October 23, 2019
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in miceSamuel Vorbach, Albert Gründer, Fengbiao Zhou, et al.Blood|March 10, 2018
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasmsJan C Peeken, Jonas S Jutzi, Julius Wehrle, et al.Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.Pageof 3